Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Immenstadt im Allgäu

7 clinical trials in Immenstadt im Allgäu, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Immenstadt im Allgäu at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Immenstadt im Allgäu

Open in trial search

Non-small cell lung cancer

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.

Non-small cell lung cancer

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Peripheral arterial occlusive disease

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Regn7508
  • Sponsor:Regeneron Pharmaceuticals Inc.

Small cell lung cancer limited stage

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Non-small cell lung cancer

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Eli Lilly & Co.

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Celgene Corp.

Non-small cell lung cancer

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Immenstadt im Allgäu

What the registry says about research in the country

01 Immenstadt im Allgäu
Respiratory Tract Diseases and Non-Small Cell Lung Cancer
In Immenstadt I. Allgäu, several recruiting studies focus on advanced and resectable non-small cell lung cancer, including patients with RET fusion-positive, EGFR-mutated, and KRAS p.G12C disease. The research is centered on comparing new treatment approaches with established standards to improve disease control and survival. Testing targeted and immunotherapy-based options for advanced lung cancer Evaluating treatment choices before and after surgery in operable disease Comparing outcomes such as progression-free survival and event-free survival Studying better options for biomarker-defined lung cancer subgroups These trials reflect a strong local interest in more personalized care for lung cancer patients.
Neoplasms and Targeted Cancer Therapy
Cancer-focused research in this city includes studies of advanced and metastatic solid tumors with specific genetic markers. The main goal is to assess whether newer targeted treatments can outperform current combinations of chemotherapy and immunotherapy. Comparing targeted therapy against standard platinum-based regimens Studying treatment effectiveness in biomarker-selected populations Looking at survival outcomes and disease progression Supporting more precise treatment selection in oncology The research highlights a broader effort to improve oncology care through better matching of therapy to tumor biology.
Hemic and Lymphatic Diseases and Myelodysplastic Syndrome
Among the recruiting trials are studies in myelodysplastic syndrome, especially in patients with low- or intermediate-risk disease. These trials are designed to evaluate a new oral treatment approach and determine how well it can support blood count recovery and disease control. Assessing a new oral therapy for lower-risk MDS Evaluating safety and effectiveness in routine clinical use Comparing treatment benefit with supportive care alone This work adds an important hematology component to the city’s clinical trial portfolio.
Immunotherapy and Surgery in Operable Lung Cancer
A separate group of studies examines how immunotherapy can be used around the time of surgery for patients with resectable non-small cell lung cancer. The purpose is to see whether adding treatment before and after surgery can improve long-term outcomes. Testing treatment given before surgery to shrink or control tumors Evaluating post-surgical therapy to reduce recurrence risk Measuring event-free survival and tumor response These trials are helping refine perioperative cancer treatment strategies for patients who may be cured with surgery.
Small Cell Lung Cancer Research
Research is also active in limited-stage small cell lung cancer, where investigators are studying combined approaches that include chemotherapy, radiotherapy, and immunotherapy. The aim is to improve treatment effectiveness in a fast-growing and challenging form of lung cancer. Exploring combined treatment strategies for limited disease Assessing how well immunotherapy adds to standard care Measuring disease control after treatment This area of research may help identify better options for patients with small cell lung cancer.
Precision Oncology for Genetically Defined NSCLC
Several studies in Germany are focused on lung cancers defined by specific molecular features, such as RET, EGFR, and KRAS alterations. The research aims to improve the match between tumor genetics and treatment choice, with the hope of delivering more effective and better-tolerated care. Comparing targeted drugs with standard treatment combinations Studying first-line options for biomarker-positive disease Evaluating outcomes in advanced and metastatic settings This is a clear example of precision medicine shaping modern cancer research.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.